APA (7th ed.) Citation

G, N., S, K., H, J., S, P., A, C., C, D., . . . R, P. (2025). Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study. Blood cancer journal, 15(1), 75. https://doi.org/10.1038/s41408-025-01279-9

Chicago Style (17th ed.) Citation

G, Narula, et al. "Novel Humanized CD19-CAR-T (Now Talicabtagene Autoleucel, Tali-cel™) Cells in Relapsed/ Refractory Pediatric B-acute Lymphoblastic Leukemia- an Open-label Single-arm Phase-I/Ib Study." Blood Cancer Journal 15, no. 1 (2025): 75. https://doi.org/10.1038/s41408-025-01279-9.

MLA (9th ed.) Citation

G, Narula, et al. "Novel Humanized CD19-CAR-T (Now Talicabtagene Autoleucel, Tali-cel™) Cells in Relapsed/ Refractory Pediatric B-acute Lymphoblastic Leukemia- an Open-label Single-arm Phase-I/Ib Study." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 75, https://doi.org/10.1038/s41408-025-01279-9.